Cargando…
Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326793/ https://www.ncbi.nlm.nih.gov/pubmed/37425409 http://dx.doi.org/10.21037/tlcr-23-173 |
| _version_ | 1785069496602460160 |
|---|---|
| author | Pons-Tostivint, Elvire |
| author_facet | Pons-Tostivint, Elvire |
| author_sort | Pons-Tostivint, Elvire |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10326793 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103267932023-07-08 Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma Pons-Tostivint, Elvire Transl Lung Cancer Res Editorial AME Publishing Company 2023-06-02 2023-06-30 /pmc/articles/PMC10326793/ /pubmed/37425409 http://dx.doi.org/10.21037/tlcr-23-173 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Pons-Tostivint, Elvire Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| title | Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| title_full | Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| title_fullStr | Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| title_full_unstemmed | Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| title_short | Gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| title_sort | gemcitabine-capecitabine: a therapeutic option in previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326793/ https://www.ncbi.nlm.nih.gov/pubmed/37425409 http://dx.doi.org/10.21037/tlcr-23-173 |
| work_keys_str_mv | AT ponstostivintelvire gemcitabinecapecitabineatherapeuticoptioninpreviouslytreatedadvancedprimarypulmonarylymphoepitheliomalikecarcinoma |